Lv1
23 积分 2021-01-25 加入
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer
7天前
已完结
Reliability analysis of the epidural spinal cord compression scale
14天前
已完结
Perioperative systemic therapy versus surgery alone for resectable colorectal peritoneal-only metastases (CAIRO6): a randomised, open-label, phase 3 trial
18天前
已完结
Clinical Significance of Recurrence Risk Score for Conversion Surgery in Patients With Advanced Gastric Cancer
20天前
已完结
The future of immune checkpoint therapy
25天前
已完结
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
25天前
已完结
Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
26天前
已完结
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
27天前
已完结
Elucidating CTLA-4’s role in tumor immunity: a comprehensive overview of targeted antibody therapies and clinical developments
28天前
已完结
Setidegrasib in Advanced Non–Small-Cell Lung Cancer and Pancreatic Cancer
2个月前
已完结
皖公网安备34019202002308
